0001104659-23-109941.txt : 20231018 0001104659-23-109941.hdr.sgml : 20231018 20231018200411 ACCESSION NUMBER: 0001104659-23-109941 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231016 FILED AS OF DATE: 20231018 DATE AS OF CHANGE: 20231018 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BILINSKY IGOR CENTRAL INDEX KEY: 0001594604 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36860 FILM NUMBER: 231333162 MAIL ADDRESS: STREET 1: C/O VICAL INCORPORATED STREET 2: 10390 PACIFIC CENTER COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IOVANCE BIOTHERAPEUTICS, INC. CENTRAL INDEX KEY: 0001425205 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 753254381 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 825 INDUSTRIAL ROAD STREET 2: 4TH FLOOR CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 6502607120 MAIL ADDRESS: STREET 1: 825 INDUSTRIAL ROAD STREET 2: 4TH FLOOR CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: Lion Biotechnologies, Inc. DATE OF NAME CHANGE: 20131015 FORMER COMPANY: FORMER CONFORMED NAME: Genesis Biopharma, Inc DATE OF NAME CHANGE: 20100319 FORMER COMPANY: FORMER CONFORMED NAME: FREIGHT MANAGEMENT CORP DATE OF NAME CHANGE: 20080128 4 1 tm2328751-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-10-16 0 0001425205 IOVANCE BIOTHERAPEUTICS, INC. IOVA 0001594604 BILINSKY IGOR C/O IOVANCE BIOTHERAPEUTICS, INC. 825 INDUSTRIAL ROAD, 4TH FLOOR SAN CARLOS CA 94070 0 1 0 0 Chief Operating Officer 0 Common Stock 2023-10-16 4 M 0 2813 0 A 30026 D Common Stock 2023-10-16 4 F 0 1395 3.57 D 28631 D Restricted Stock Units 2023-10-16 4 M 0 2813 0.00 D Common stock 2813 14064 D Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. Represents common stock remaining after deducting the common stock withheld for taxes. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in five equal quarterly installments. /s/ Igor Bilinsky 2023-10-18